Zobrazeno 1 - 10
of 43
pro vyhledávání: '"M J Del Cerro"'
Autor:
M. Álvarez-Fuente, M. Toledano, E. Garrido-Lestache, I. Sánchez, I. Molina, N. Rivero, I. García-Ormazábal, M. J. del Cerro
Publikováno v:
Pediatric Cardiology.
Autor:
J Playan Escribano, E Garrido-Lestache, R Luna, M Alvarez Fuente, M Lopez-Meseguer, I Guillen Rodriguez, G M Perez Penate, A Sabate Rotes, T Elias Hernandez, M Lopez Ramon, J Rueda Soriano, F Perin, I Blanco, M J Del Cerro Marin, P Escribano Subias
Publikováno v:
European Heart Journal. 43
Pulmonary arterial hypertension (PAH) is a common complication of congenital heart disease (CHD) that significantly affects its prognosis. Down syndrome is a common comorbidity among patients with PAH associated with CHD. Children born in recent year
Autor:
A Marschall, M Alvarez-Fuente, E Garrido-Lestache, L Tellez, I Sanchez, M Toledano, I Molina, N Rivero, I Garcia-Ormazabal, R Tamariz, M J Del Cerro
Publikováno v:
European Heart Journal. 43
Background In light of increased survival of patients with Fontan circulation, percutaneous interventions in these patients have become growingly significant in the recent years. Percutaneous treatments in patients with univentricular physiology can
Autor:
J Playan Escribano, E Garrido-Lestache, M J Cristo Ropero, M Alvarez Fuente, J A Barbera, A Moreno Galdo, J Rueda Soriano, A Rodriguez Ogando, T Elias Hernandez, I Guillen Rodriguez, M Lazaro Salvador, M Lozano Balseiro, A Lara Padron, P Escribano Subias, M J Del Cerro Marin
Publikováno v:
European Heart Journal. 42
Introduction Eisenmenger syndrome is the final clinical stage of different congenital heart diseases (CHD) associated with pulmonary arterial hypertension (PAH). Children born in recent years with CHD have benefited from advances in pediatric cardiac
Autor:
A Cruz Utrilla, N Gallego, A Torrent, E Garrido-Lestache, I Guillen, S Arias, A Moya, A Mendoza, J Espin, M M Rodriguez Vazquez, J Playan-Escribano, C Labrandero, J A Tenorio Castano, P Escribano Subias, M J Del Cerro
Publikováno v:
European Heart Journal. 42
Background Pulmonary arterial hypertension (PAH) is a rare and severe disease, genetically predisposed in a high proportion of patients. PAH is subclassified in different subtypes depending on the underlying condition. Gene variants are more frequent
Autor:
M J, del Cerro Marín, A, Sabaté Rotés, A, Rodriguez Ogando, A, Mendoza Soto, M, Quero Jiménez, J L, Gavilán Camacho, I, Raposo Sonnenfeld, A, Moya Bonora, D C, Albert Brotons, A, Moreno Galdó, S, Villagra
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 190:1421-1429
There is a lack of knowledge regarding the epidemiology, clinical characterization, and survival in pediatric pulmonary hypertension.To describe the epidemiology, outcomes, and risk factors for mortality in pediatric pulmonary hypertension in Spain.W
Autor:
Ogando A.R. Rodriguez, E. Garrido, M. J. Del Cerro, Carlos Labrandero, Alberto Mendoza, Dimpna C. Albert, C. Blanco, Judit Grueso
Publikováno v:
The Thoracic and Cardiovascular Surgeon. 64
Autor:
I. Sánchez, Gómez R, M. Cuesta, José Luis Zunzunegui, M. J. Del Cerro, Luis Carlos Martínez Fernández, Martha Isabel Gómez Álvarez, M. Martínes, Cesar Abelleira
Publikováno v:
The Thoracic and Cardiovascular Surgeon. 64
Autor:
L. Hierro, Ángel Aroca, C. Díaz, Islay Rodríguez, E. Alonso Villán, Jenny Rodriguez, J. Pérez Rodríguez, A. Iglesias, Soto C, A. Lahoz, M. J. Del Cerro, J.I. del Diego, A. García Pose, Purificación García-Miguel, A. Asensio, J.A. Ruiz
Publikováno v:
Anales de Pediatría, Vol 76, Iss 6, Pp 343-349 (2012)
Resumen: Objetivo: Analizar la mortalidad en un hospital infantil de tercer nivel y alta complejidad. Material y métodos: Se revisaron los fallecidos en el Hospital Infantil La Paz durante los años 2007, 2008 y 2009. Se analizaron datos epidemioló
Autor:
Elvira Garrido-Lestache, E Barrios, I. Sánchez, Gómez R, R Tamariz, M. J. Del Cerro, L. Fernández-Pineda, Blanca Romera, María J. Lamas, Sandra Villagrá, María Álvarez-Fuente, Tomasa Centella, Cesar Abelleira
Publikováno v:
Pediatric cardiology. 37(3)
Congenital heart disease patients that develop secondary pulmonary regurgitation require a pulmonary valve replacement (PVR) in their follow-up. The indications for PVR in asymptomatic patients are debated. Most guidelines consider a RV end-diastolic